Extracorporeal Membrane Oxygenation System Market Growth With Healthy CAGR of 5.3% to reach US$ 476.8 Mn by 2028 | Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation

Extra Corporeal Membrane Oxygenation (ECMO) has become inevitable tool in the care of adults and children with severe cardiac and pulmonary dysfunction. Cardiovascular disease is the leading cause of deaths, globally.

A silicone lung is another type of extracorporeal membrane oxygenation system. This implant consists of a flat reinforced silicone rubber membrane envelope wrapped around a wire mesh spiral. Blood flows in counter-current directions through the silicone lung. Oxygen and CO2 are exchanged by diffusion across the silicone membrane. Despite this method being effective, it does not work well with centrifugal pumps. It does have some limitations, however, and patients may need more than one type.

Get PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/947

The ECMO market is fueled by increasing number of organ transplant surgeries. The increasing prevalence of cardiovascular diseases and respiratory disorders has increased the demand for the ECMO device.

Key players in the market are focusing on continuous evolution of technologically and expanding geographically by approval from regulatory bodies. In 2015, ALung technologies, Inc. launched next generation Hemolung CR4 controller, a part of Hemolung Respiratory Assist System, which provides minimally invasive extracorporeal CO₂ removal as an alternative or supplement to mechanical ventilation for patients suffering from acute respiratory failure. For instance, in April 2017, ALung Technologies, Inc., received U.S. Food and Drug Administration (FDA) approval for Hemolung, Respiratory Assist System, for treatment of severe COPD in adults. The approval will initiate ALung’s VENT-AVOID Trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations. The education and training programs held by organizations are expected to create awareness among population. For instance, Extracorporeal Life Support Organization (ELSO) are involved in providing support to institutions delivering extracorporeal life support through continuing education and maintenance of a comprehensive registry of patient data. For instance, ELSO is organizing 7^th EuroELSO Congress on ECMO-ELCS in May 2018, aiming to provide education about adult, pediatric and perfusion related to extracorporeal therapies. Moreover, in July 2018, Asia Pacific ELSO is conducting adult ECMO training course in Queen Mary Hospital in Hong Kong. Moreover, policies such as Premera covers the medical insurance for the use of ECMO in adults, which will also help in growth of ECMO system market.

Key takeaways of the Extracorporeal Membrane Oxygenation System Market:

• The global extracorporeal membrane oxygenation system market is expected to expand at a CAGR of 5.2% during the forecast period (2018 – 2026), owing to presence of untapped and highly lucrative market especially in Asia Pacific, Latin America, Middle East, and Africa.
• Efficiency and reliability of venovenous ECMO is expected to make venovenous ECMO a dominant segment in modality segment
• In the segment by application, respiratory segment will hold larger share attributed by high incidence of patience with respiratory disorder
• Neonatal segment is subjected to experience growth due to increasing incidence of congenital heart disease
• North America hold dominant position in ECMO system market, owing to its well-developed infrastructure and better reimbursement policies
• Some of the major players involved in global extracorporeal membrane oxygenation system market include Medtronic Plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation, and Alung technologies Inc.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/947

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Extracorporeal Membrane Oxygenation System Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Extracorporeal Membrane Oxygenation System Industry Impact

Chapter 2 Global Extracorporeal Membrane Oxygenation System Competition by Types, Applications, and Top Regions and Countries
2.1 Global Extracorporeal Membrane Oxygenation System (Volume and Value) by Type
2.3 Global Extracorporeal Membrane Oxygenation System (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Extracorporeal Membrane Oxygenation System Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 6 East Asia Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 7 Europe Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 8 South Asia Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 9 Southeast Asia Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 10 Middle East Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 11 Africa Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 12 Oceania Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 13 South America Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 14 Company Profiles and Key Figures in Extracorporeal Membrane Oxygenation System Business
Chapter 15 Global Extracorporeal Membrane Oxygenation System Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology

Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/947